5/29
04:15 pm
enlv
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
Medium
Report
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
5/28
08:24 am
enlv
Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering [Yahoo! Finance]
Medium
Report
Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering [Yahoo! Finance]
5/28
08:12 am
enlv
Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering
High
Report
Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering
5/21
02:02 pm
enlv
We're Keeping An Eye On Enlivex Therapeutics' (NASDAQ:ENLV) Cash Burn Rate [Yahoo! Finance]
Low
Report
We're Keeping An Eye On Enlivex Therapeutics' (NASDAQ:ENLV) Cash Burn Rate [Yahoo! Finance]
4/29
08:10 am
enlv
Enlivex CEO Issues Letter to Shareholders – Perspectives on Recent Events [Yahoo! Finance]
High
Report
Enlivex CEO Issues Letter to Shareholders – Perspectives on Recent Events [Yahoo! Finance]
4/29
08:00 am
enlv
Enlivex CEO Issues Letter to Shareholders – Perspectives on Recent Events
High
Report
Enlivex CEO Issues Letter to Shareholders – Perspectives on Recent Events
4/23
08:09 am
enlv
Enlivex Therapeutics Ltd. (NASDAQ: ENLV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Medium
Report
Enlivex Therapeutics Ltd. (NASDAQ: ENLV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
4/22
08:00 am
enlv
Enlivex Announces Dosing of First Two Patients in its Randomized, Controlled Phase I/II Trial Evaluating Allocetra™ in Patients with Knee Osteoarthritis
Low
Report
Enlivex Announces Dosing of First Two Patients in its Randomized, Controlled Phase I/II Trial Evaluating Allocetra™ in Patients with Knee Osteoarthritis
4/16
08:08 am
enlv
Enlivex Announces Authorization from the Danish Regulatory Agency for the Company's Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis [Yahoo! Finance]
Medium
Report
Enlivex Announces Authorization from the Danish Regulatory Agency for the Company's Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis [Yahoo! Finance]
4/16
07:50 am
enlv
Enlivex Announces Authorization from the Danish Regulatory Agency for the Company’s Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis
High
Report
Enlivex Announces Authorization from the Danish Regulatory Agency for the Company’s Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis
4/15
03:05 pm
enlv
Enlivex (ENLV) Stock Plummets 51% in a Week: Here's Why [Yahoo! Finance]
Medium
Report
Enlivex (ENLV) Stock Plummets 51% in a Week: Here's Why [Yahoo! Finance]
4/12
08:00 am
enlv
Enlivex Therapeutics Ltd. (NASDAQ: ENLV) had its price target lowered by analysts at HC Wainwright from $12.00 to $7.00. They now have a "buy" rating on the stock.
High
Report
Enlivex Therapeutics Ltd. (NASDAQ: ENLV) had its price target lowered by analysts at HC Wainwright from $12.00 to $7.00. They now have a "buy" rating on the stock.
3/22
11:07 am
enlv
Enlivex Therapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV [Yahoo! Finance]
Low
Report
Enlivex Therapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV [Yahoo! Finance]
3/22
10:50 am
enlv
Enlivex Therapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Low
Report
Enlivex Therapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV